Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Molecular remission and response patterns in patients with mutant-IDH2 acute myeloid leukemia treated with enasidenib.

Stein EM, DiNardo CD, Fathi AT, Pollyea DA, Stone RM, Altman JK, Roboz GJ, Patel MR, Collins R, Flinn IW, Sekeres MA, Stein AS, Kantarjian HM, Levine RL, Vyas P, MacBeth KJ, Tosolini A, VanOostendorp J, Xu Q, Gupta I, Lila T, Risueno A, Yen KE, Wu B, Attar EC, Tallman MS, de Botton S.

Blood. 2019 Feb 14;133(7):676-687. doi: 10.1182/blood-2018-08-869008. Epub 2018 Dec 3.

2.

Clinical features of adolescents with deliberate self-harm: A case control study in Lisbon, Portugal.

Guerreiro DF, Neves EL, Navarro R, Mendes R, Prioste A, Ribeiro D, Lila T, Neves A, Salgado M, Santos N, Sampaio D.

Neuropsychiatr Dis Treat. 2009;5:611-7. Epub 2009 Nov 16.

3.

Molecular basis for fungal selectivity of novel antimitotic compounds.

Lila T, Renau TE, Wilson L, Philips J, Natsoulis G, Cope MJ, Watkins WJ, Buysse J.

Antimicrob Agents Chemother. 2003 Jul;47(7):2273-82.

4.

A streamlined process to phenotypically profile heterologous cDNAs in parallel using yeast cell-based assays.

Tugendreich S, Perkins E, Couto J, Barthmaier P, Sun D, Tang S, Tulac S, Nguyen A, Yeh E, Mays A, Wallace E, Lila T, Shivak D, Prichard M, Andrejka L, Kim R, Melese T.

Genome Res. 2001 Nov;11(11):1899-912.

7.

A conserved proline-rich region of the Saccharomyces cerevisiae cyclase-associated protein binds SH3 domains and modulates cytoskeletal localization.

Freeman NL, Lila T, Mintzer KA, Chen Z, Pahk AJ, Ren R, Drubin DG, Field J.

Mol Cell Biol. 1996 Feb;16(2):548-56.

8.
9.

Analysis of the enhancer element that controls expression of sevenless in the developing Drosophila eye.

Bowtell DD, Lila T, Michael WM, Hackett D, Rubin GM.

Proc Natl Acad Sci U S A. 1991 Aug 1;88(15):6853-7.

Supplemental Content

Support Center